Ohio Public Employees Retirement System (OPERS)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.2M Sell
56,590
-5,973
-10% -$348K 0.01% 855
2025
Q4
$3.72M Buy
62,563
+2,136
+4% +$116K 0.01% 821
2025
Q3
$3.27M Buy
60,427
+532
+0.9% +$30.4K 0.01% 877
2025
Q2
$3.29M Buy
59,895
+988
+2% +$58.2K 0.01% 859
2025
Q1
$4.16M Sell
58,907
-6,576
-10% -$442K 0.02% 732
2024
Q4
$4.3M Sell
65,483
-3,630
-5% -$243K 0.01% 766
2024
Q3
$4.86M Sell
69,113
-6,819
-9% -$570K 0.02% 685
2024
Q2
$6.25M Sell
75,932
-1,549
-2% -$129K 0.02% 518
2024
Q1
$6.77M Sell
77,481
-8,268
-10% -$740K 0.03% 516
2023
Q4
$8.27M Buy
85,749
+722
+0.8% +$63.9K 0.03% 439
2023
Q3
$7.52M Sell
85,027
-8,435
-9% -$751K 0.03% 424
2023
Q2
$8.1M Sell
93,462
-7,075
-7% -$666K 0.03% 439
2023
Q1
$9.78M Buy
100,537
+5,525
+6% +$573K 0.04% 393
2022
Q4
$9.83M Buy
95,012
+1,128
+1% +$106K 0.04% 383
2022
Q3
$7.96M Buy
93,884
+711
+0.8% +$63.3K 0.04% 426
2022
Q2
$7.72M Sell
93,173
-2,923
-3% -$233K 0.03% 463
2022
Q1
$7.41M Sell
96,096
-3,251
-3% -$272K 0.03% 569
2021
Q4
$8.78M Sell
99,347
-3,596
-3% -$297K 0.03% 516
2021
Q3
$7.96M Sell
102,943
-2,133
-2% -$168K 0.03% 544
2021
Q2
$8.77M Buy
105,076
+6,405
+6% +$508K 0.03% 520
2021
Q1
$7.45M Buy
98,671
+7,211
+8% +$589K 0.03% 534
2020
Q4
$8.02M Buy
91,460
+17,317
+23% +$1.37M 0.04% 436
2020
Q3
$5.64M Buy
74,143
+4,661
+7% +$472K 0.03% 454
2020
Q2
$8.57M Sell
69,482
-3,157
-4% -$314K 0.05% 342
2020
Q1
$6.14M Buy
72,639
+10,979
+18% +$946K 0.04% 378
2019
Q4
$5.21M Buy
61,660
+780
+1% +$58.9K 0.03% 524
2019
Q3
$4.1M Buy
60,880
+288
+0.5% +$22.2K 0.02% 638
2019
Q2
$5.19M Sell
60,592
-3,414
-5% -$292K 0.03% 532
2019
Q1
$5.69M Sell
64,006
-12,169
-16% -$1.13M 0.03% 521
2018
Q4
$6.49M Sell
76,175
-4,823
-6% -$459K 0.04% 415
2018
Q3
$7.85M Sell
80,998
-3,069
-4% -$306K 0.04% 441
2018
Q2
$7.92M Sell
84,067
-3,991
-5% -$350K 0.04% 446
2018
Q1
$7.14M Sell
88,058
-18,730
-18% -$1.61M 0.04% 475
2017
Q4
$9.52M Buy
106,788
+126
+0.1% +$11K 0.05% 385
2017
Q3
$9.93M Sell
106,662
-2,333
-2% -$206K 0.05% 359
2017
Q2
$9.9M Sell
108,995
-7,505
-6% -$683K 0.05% 360
2017
Q1
$10.2M Hold
116,500
0.06% 352
2016
Q4
$10.5M Buy
116,500
+5,281
+5% +$454K 0.06% 346
2016
Q3
$10.3M Buy
111,219
+23,238
+26% +$2.19M 0.06% 316
2016
Q2
$6.84M Buy
87,981
+7,047
+9% +$599K 0.04% 401
2016
Q1
$6.67M Buy
80,934
+18,787
+30% +$1.53M 0.04% 396
2015
Q4
$6.51M Sell
62,147
-16,244
-21% -$1.7M 0.04% 426
2015
Q3
$8.26M Sell
78,391
-8,780
-10% -$1.17M 0.05% 365
2015
Q2
$11.9M Buy
87,171
+8,647
+11% +$1.07M 0.07% 315
2015
Q1
$9.79M Buy
78,524
+26,524
+51% +$2.81M 0.06% 361
2014
Q4
$4.7M Buy
52,000
+11,054
+27% +$919K 0.03% 573
2014
Q3
$2.96M Sell
40,946
-3,188
-7% -$210K 0.02% 725
2014
Q2
$2.75M Sell
44,134
-3,706
-8% -$224K 0.02% 789
2014
Q1
$3.26M Sell
47,840
-9,504
-17% -$700K 0.02% 689
2013
Q4
$4.03M Buy
57,344
+6,506
+13% +$442K 0.02% 670
2013
Q3
$3.67M Buy
50,838
+9,212
+22% +$612K 0.02% 719
2013
Q2
$2.32M Buy
+41,626
New +$2.59M 0.01% 844

Other funds holding BMRN